After estrogen treatment, however, the number of cells co-expressing both PCNA and CK18 was markedly increased (Figure 5C), indicating estrogen stimulates proliferation of luminal epithelial lineage specific breast cancer progenitor or intermediate cells. The gene discussed is KRT18; the disease is breast cancer.